17-44170872-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080863.5(ASB16):c.83G>A(p.Arg28Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000937 in 1,611,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. R28R) has been classified as Likely benign.
Frequency
Consequence
NM_080863.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASB16 | ENST00000293414.6 | c.83G>A | p.Arg28Gln | missense_variant | Exon 1 of 5 | 1 | NM_080863.5 | ENSP00000293414.1 | ||
ASB16 | ENST00000589618.1 | n.83G>A | non_coding_transcript_exon_variant | Exon 1 of 5 | 1 | ENSP00000466033.1 | ||||
ASB16 | ENST00000591700 | c.-170G>A | 5_prime_UTR_variant | Exon 2 of 3 | 4 | ENSP00000466349.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152154Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000176 AC: 43AN: 243826Hom.: 0 AF XY: 0.000187 AC XY: 25AN XY: 133358
GnomAD4 exome AF: 0.0000932 AC: 136AN: 1458992Hom.: 0 Cov.: 29 AF XY: 0.000107 AC XY: 78AN XY: 725706
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152154Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.83G>A (p.R28Q) alteration is located in exon 1 (coding exon 1) of the ASB16 gene. This alteration results from a G to A substitution at nucleotide position 83, causing the arginine (R) at amino acid position 28 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at